Shim Jihyun, Shin Yonguk, Lee Imsang, Kim So Young
Research Institute of Biotechnology, CJ CheilJedang Corp., CJ Blossom Park. 55, Gwanggyo-ro 42beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16495, South Korea.
Adv Biochem Eng Biotechnol. 2017;159:153-177. doi: 10.1007/10_2016_30.
L-Methionine has been used in various industrial applications such as the production of feed and food additives and has been used as a raw material for medical supplies and drugs. It functions not only as an essential amino acid but also as a physiological effector, for example, by inhibiting fat accumulation and enhancing immune response. Producing methionine from fermentation is beneficial in that microorganisms can produce L-methionine selectively using eco-sustainable processes. Nevertheless, the fermentative method has not been used on an industrial scale because it is not competitive economically compared with chemical synthesis methods. Presented are efforts to develop suitable strains, engineered enzymes, and alternative process of producing L-methionine that overcomes problems of conventional fermentation methods. One of the alternative processes is a two-step process in which the L-methionine precursor is produced by fermentation and then converted to L-methionine by enzymes. Directed efforts toward strain development and enhanced enzyme engineering will advance industrial production of L-methionine based on fermentation.
L-蛋氨酸已用于各种工业应用,如饲料和食品添加剂的生产,并被用作医疗用品和药物的原料。它不仅作为必需氨基酸发挥作用,还作为生理效应物,例如通过抑制脂肪积累和增强免疫反应。通过发酵生产蛋氨酸是有益的,因为微生物可以使用生态可持续的方法选择性地生产L-蛋氨酸。然而,发酵法尚未在工业规模上使用,因为与化学合成法相比,它在经济上没有竞争力。目前正在努力开发合适的菌株、工程酶以及生产L-蛋氨酸的替代工艺,以克服传统发酵方法的问题。替代工艺之一是两步法,其中L-蛋氨酸前体通过发酵产生,然后通过酶转化为L-蛋氨酸。针对菌株开发和增强酶工程的定向努力将推动基于发酵的L-蛋氨酸的工业化生产。